CompletedPhase 2ACTRN12611000745943

The Natural History of the Pudendal Nerve Block

Natural history of Pudendal nerve block in female patients with chronic perineal pain


Sponsor

Royal Hospital for Women

Enrollment

150 participants

Start Date

Oct 1, 2008

Study Type

Interventional

Conditions

Summary

The firsrt aim of the study is to identify precisely how long a pudendal nerve block lasts and to find out how the different symptoms of pudendal neuralgia presented by the patient, evolve during the 52 hours following the pudendal nerve block. The second aim is to find out, for patients undergoing afterwards the pudendal nerve release surgery, if there is a correlation between the particular response to pudendal nerve block and the outcome after surgery. This will be a prospective study based on questionnaires. It will include a minimum of 50 women aged 18 or more, who had been referred to the Pudendal nerve Clinic in the Endogynaecology Department at the Royal Hospital for Women, who meet the entry criteria and who already consented to undergo a pudendal nerve block as part of their assessment. The participant will be asked to fill in a questionnaire, always the same, about her symptoms before, just after and then every 6 then 8 hours for 52 hours after the pudendal nerve block. If the patient undergoes a surgery to release the pudendal nerve entrapment, we will ask her to fill in that same questionnaire again 3, 6 and 12 months after the surgery.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tracks the natural history and outcomes of pudendal nerve blocks in women aged 18 and older who have been diagnosed with pudendal neuralgia (chronic pelvic pain caused by the pudendal nerve). The research follows patients over time after they receive the nerve block treatment. The goal is to understand how effective and long-lasting pudendal nerve blocks are for managing this painful condition.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This injection is done by vaginal way, on both sides in the operating theatre under sedation. We inject 10ml of Ropivacaine, an amide-type local anesthetic, at a concentration 0.75% in each Alcock’s c

This injection is done by vaginal way, on both sides in the operating theatre under sedation. We inject 10ml of Ropivacaine, an amide-type local anesthetic, at a concentration 0.75% in each Alcock’s canal. We observed that after the block, the different symptoms return at different times after the block.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000745943